Mechanistic Differences Leading to Infectious and Sterile Inflammation

American Journal of Reproductive Immunology

Volumn 75, Issue 5, 2016, Pages 505-518

  Behnia, Faranak ^a   Sheller, Samantha ^a   Menon, Ramkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Oxidative stress; Preterm birth; Senescence; Sterile inflammation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38;

AMNION CELL; ENZYME ACTIVATION; EPITHELIUM CELL; FETUS (ANATOMY); HUMAN; INFECTIOUS INFLAMMATION; INFLAMMATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENESCENCE; SIGNAL TRANSDUCTION; ANIMAL; BIRTH; CELL AGING; FEMALE; IMMUNOLOGY; INFECTION; METABOLISM; PREGNANCY;

ANIMALS; CELL AGING; FEMALE; HUMANS; INFECTION; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; OXIDATIVE STRESS; PARTURITION; PREGNANCY; PREGNANCY OUTCOME;

EID: 84959045112     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12496     Document Type: Review

References (140)

1. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF: The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88:31-38.
2. Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V: Why the United States preterm birth rate is declining. Am J Obstet Gynecol 2015; 213:175-180.
3. McCormick MC: The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312:82-90.
4. Menon R: Preterm birth: a global burden on maternal and child health. Pathog Glob Health 2012; 106:139-140.
5. Menon R, Conneely KN, Smith AK: DNA methylation: an epigenetic risk factor in preterm birth. Reprod Sci 2012; 19:6-13.
6. Peltier MR, Drobek CO, Bhat G, Saade G, Fortunato SJ, Menon R: Amniotic fluid and maternal race influence responsiveness of fetal membranes to bacteria. J Reprod Immunol 2012; 96:68-78.
7. Abrahams VM, Potter JA, Bhat G, Peltier MR, Saade G, Menon R: Bacterial modulation of human fetal membrane Toll-like receptor expression. Am J Reprod Immunol 2013; 69:33-40.
8. Menon R, Peltier MR, Eckardt J, Fortunato SJ: Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol 2009; 201:306.
9. Bhat G, Peltier MR, Syed TA, Drobek CO, Saade G, Menon R: Fetal membrane biomarker network diversity and disease functions induced by intra-amniotic pathogens. Am J Reprod Immunol 2013; 69:124-133.
10. Ward K: Genetic factors in preterm birth. BJOG 2003; 110(Suppl 20):117.
11. Esplin MS, Varner MW: Genetic factors in preterm birth-the future. BJOG 2005; 112(Suppl 1):97-102.
12. Goldenberg RL, Cliver SP, Mulvihill FX, Hickey CA, Hoffman HJ, Klerman LV, Johnson MJ: Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among black women. Am J Obstet Gynecol 1996; 175:1317-1324.
13. Byrnes J, Mahoney R, Quaintance C, Gould JB, Carmichael S, Shaw GM, Showen A, Phibbs C, Stevenson DK, Wise PH: Spatial and temporal patterns in preterm birth in the United States. Pediatr Res 2015; 77:836-844.
14. Kallan JE: Reexamination of interpregnancy intervals and subsequent birth outcomes: evidence from U.S. linked birth/infant death records. Soc Biol 1997; 44:205-212.
15. El-Bastawissi AY, Sorensen TK, Akafomo CK, Frederick IO, Xiao R, Williams MA: History of fetal loss and other adverse pregnancy outcomes in relation to subsequent risk of preterm delivery. Matern Child Health J 2003; 7:53-58.
16. Smith LK, Draper ES, Manktelow BN, Dorling JS, Field DJ: Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed 2007; 92:F11-F14.
17. Brett KM, Strogatz DS, Savitz DA: Employment, job strain, and preterm delivery among women in North Carolina. Am J Public Health 1997; 87:199-204.
18. Xinxo S, Bimbashi A, Kakarriqi Z, Zaimi E: Association between maternal nutritional status of pre pregnancy, gestational weight gain and preterm birth. Mater Sociomed 2013; 25:6-8.
19. Moutquin JM: Socio-economic and psychosocial factors in the management and prevention of preterm labour. BJOG 2003; 110(Suppl 20):56-60.
20. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S: Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25:1175-1182.
21. Christiaens I, Hegadoren K, Olson DM: Adverse childhood experiences are associated with spontaneous preterm birth: a case-control study. BMC Med 2015; 13:124.
22. Prince AL, Antony KM, Chu DM, Aagaard KM: The microbiome, parturition, and timing of birth: more questions than answers. J Reprod Immunol 2014; 104-105:12-19.
23. Nordentoft M, Lou HC, Hansen D, Nim J, Pryds OA, Rubin PJ, Hemmingsen RP: Intrauterine growth retardation and premature delivery: the influence of maternal smoking and psychosocial factors. Am J Public Health 1996; 86:347-354.
24. Meis PJ, Goldenberg RL, Mercer BM, Iams J, Moaward A, Miodovnik M, Menard M, Caritis S, Thurnau G, Bottoms S, Das A, Roberts J, McNellis D: The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol 1998; 178:562-567.
25. Holzman C, Paneth N: Maternal cocaine use during pregnancy and perinatal outcomes. Epidemiol Rev 1994; 16:315-334.
26. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC: Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12:262-279.
27. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S: The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25:21-39.
28. Romero R, Dey SK, Fisher SJ: Preterm labor: one syndrome, many causes. Science 2014; 345:760-765.
29. Lee J, Romero R, Chaiworapongsa T, Dong Z, Tarca A, Xu Y, Chiang P, Kusanovic J, Hassan S, Yeo L, Yoon B, Than N, Kim C: Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol 2013; 70:265-284.
30. Wegorzewska M, Nijagal A, Wong CM, Le T, Lescano N, Tang Q, MacKenzie T: Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise. J Immunol 2014; 192:1938-1945.
31. Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, Petraglia F: Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update 2016; 22:104-115.
32. Petraglia F, Imperatore A, Challis JR: Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010; 31:783-816.
33. Romero R, Kusanovic JP, Munoz H, Gomez R, Lamont RF, Yeo L: Allergy-induced preterm labor after the ingestion of shellfish. J Matern Fetal Neonatal Med 2010; 23:351-359.
34. Adams Waldorf KM, Singh N, Mohan AR, Young RC, Ngo L, Das A, Tsai J, Bansal A, Paolella L, Herbert BR, Sooranna SR, Gough GM, Astley C, Vogel K, Baldessari AE, Bammler TK, MacDonald J, Gravett MG, Rajagopal L, Johnson MR: Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates. Am J Obstet Gynecol 2015; 213:830.e1-830.e19.
35. Elovitz MA, Saunders T, Ascher-Landsberg J, Phillippe M: Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol 2000; 183:799-804.
36. Han CS, Schatz F, Lockwood CJ: Abruption-associated prematurity. Clin Perinatol 2011; 38:407-421.
37. Iams JD, Goldenberg RL, Meis PJ, Mercer B, Moawad A, Das A, Thom E, McNellis D, Copper R, Johnson F, Roberts J: The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996; 334:567-572.
38. Many A, Hill LM, Lazebnik N, Martin JG: The association between polyhydramnios and preterm delivery. Obstet Gynecol 1995; 86:389-391.
39. Savitz DA, Blackmore CA, Thorp JM: Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. Am J Obstet Gynecol 1991; 164:467-471.
40. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M: The preterm parturition syndrome. BJOG 2006; 113(Suppl 3):17-42.
41. Petraglia F, Giardino L, Coukos G, Calza L, Vale W, Genazzani AR: Corticotropin-releasing factor and parturition: plasma and amniotic fluid levels and placental binding sites. Obstet Gynecol 1990; 75:784-789.
42. Mesiano S: Roles of estrogen and progesterone in human parturition. Front Horm Res 2001; 27:86-104.
43. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R: A placental clock controlling the length of human pregnancy. Nat Med 1995; 1:460-463.
44. Nemeth E, Millar LK, Bryant-Greenwood G: Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro. Am J Obstet Gynecol 2000; 182:60-67.
45. Cha J, Bartos A, Egashira M, Haraguchi H, Saito-Fujita T, Leishman E, Bradshaw H, Dey S, Hirota Y: Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions. J Clin Invest 2013; 123:4063-4075.
46. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R: Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002; 87:2924-2930.
47. Mesiano S, Welsh TN: Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol 2007; 18:321-331.
48. Mesiano S: Myometrial progesterone responsiveness. Semin Reprod Med 2007; 25:5-13.
49. Mesiano S, Wang Y, Norwitz ER: Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing? Reprod Sci 2011; 18:6-19.
50. Suresh A, Subedi K, Kyathanahalli C, Jeyasuria P, Condon JC: Uterine endoplasmic reticulum stress and its unfolded protein response may regulate caspase 3 activation in the pregnant mouse uterus. PLoS ONE 2013; 8:e75152.
51. Papiernik E, Bouyer J, Collin D, Winisdoerffer G, Dreyfus J: Precocious cervical ripening and preterm labor. Obstet Gynecol 1986; 67:238-242.
52. Filipovich Y, Klein J, Zhou Y, Hirsch E: Maternal and fetal roles in bacterially-induced preterm labor in the mouse. Am J Obstet Gynecol 2015; pii:S0002-9378(15)01277-6. [Epub ahead of print].
53. Gravett MG, Adams KM, Sadowsky DW, Grosvenor A, Witkin S, Axthelm M, Novy M: Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007; 197:518.
54. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ: An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171:1660-1667.
55. Nielsen BW, Bonney EA, Pearce BD, Donahue LR, Sarkar IN: A cross-species analysis of animal models for the investigation of preterm birth mechanisms. Reprod Sci 2015; pii:1933719115604729. [Epub ahead of print].
56. Regan JK, Kannan PS, Kemp MW, Kramer B, Newnham J, Jobe A, Kallapur S: Damage-associated molecular pattern and fetal membrane vascular injury and collagen disorganization in lipopolysaccharide-induced intra-amniotic inflammation in fetal sheep. Reprod Sci 2016; 23:69-80.
57. Menon R, Fortunato SJ: Distinct pathophysiologic pathways induced by in vitro infection and cigarette smoke in normal human fetal membranes. Am J Obstet Gynecol 2009; 200:334-338.
58. Bennett PR, Elder MG, Myatt L: The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987; 33:837-844.
59. Carraher R, Hahn DW, Ritchie DM, McGuire JL: Involvement of lipoxygenase products in myometrial contractions. Prostaglandins 1983; 26:23-32.
60. Crankshaw D: Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro. Eur J Pharmacol 1995; 285:151-158.
61. Heluy V, Germain G, Fournier T, Ferre F, Breuiller-Fouche M: Endothelin ETA receptors mediate human uterine smooth muscle contraction. Eur J Pharmacol 1995; 285:89-94.
62. Chan RL: Biochemical markers of spontaneous preterm birth in asymptomatic women. Biomed Res Int 2014; 2014:164081.
63. Parets SE, Bedient CE, Menon R, Smith AK: Preterm birth and its long-term effects: methylation to mechanisms. Biology (Basel) 2014; 3:498-513.
64. Norman JE, Bollapragada S, Yuan M, Nelson SM: Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth 2007; 7(Suppl 1):S7.
65. Romero R, Espinoza J, Chaiworapongsa T, Kalache K: Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002; 7:259-274.
66. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski S, Chaemsaithong P, Gotsch F, Dong Z, Ahmed A, Yoon B, Hassan S, Kim C, Yeo L: Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol 2014; 72:458-474.
67. Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G: Viral infections during pregnancy. Am J Reprod Immunol 2015; 73:199-213.
68. Kwon JY, Romero R, Mor G: New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol 2014; 71:387-390.
69. Ticconi C, Mapfumo M, Dorrucci M, Naha N, Tarira E, Pietropolli A, Rezza G: Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003; 34:289-294.
70. Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, Semprini AE, Salt A, Gilbert R: Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG 2005; 112:31-37.
71. Schieve LA, Handler A, Hershow R, Persky V, Davis F: Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health 1994; 84:405-410.
72. Scannapieco FA, Bush RB, Paju S: Periodontal disease as a risk factor for adverse pregnancy outcomes. A systematic review. Ann Periodontol 2003; 8:70-78.
73. Khader YS, Ta'ani Q: Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. J Periodontol 2005; 76:161-165.
74. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G: Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190:1509-1519.
75. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis A, Hobbins J: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161:817-824.
76. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A: Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989; 161:336-341.
77. Gervasi MT, Romero R, Bracalente G, Erez O, Dong Z, Hassan S, Yeo L, Yoon BH, Chaiworapongsa T: Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012; 40:329-343.
78. Kim CJ, Romero R, Chaemsaithong P, Kim JS: Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol 2015; 213:S53-S69.
79. Kalinka J, Wasiela M, Sobala W, Brzezinska-Blaszczyk E: [Usefulness assessment of selected proinflammatory cytokines' level in cervico-vaginal fluid of pregnant women as an early marker of preterm delivery]. Ginekol Pol 2005; 76:704-712.
80. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM: Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213:S29-S52.
81. Simcox R, Sin WT, Seed PT, Briley A, Shennan AH: Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol 2007; 47:368-377.
82. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348:2379-2385.
83. Andrews WW, Copper R, Hauth JC, Goldenberg RL, Neely C, Dubard M: Second-trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 2000; 95:222-226.
84. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188:419-424.
85. Haram K, Mortensen JH, Morrison JC: Tocolysis for acute preterm labor: does anything work. J Matern Fetal Neonatal Med 2015; 28:371-378.
86. Reinebrant HE, Pileggi-Castro C, Romero CL, Dos Santos RA, Kumar S, Souza JP, Flenady V: Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2015; 6:CD001992.
87. Kacerovsky M, Celec P, Vlkova B, Skogstrand K, Hougarrd D, Cobo T, Jacobsson B: Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PLoS ONE 2013; 8:e60399.
88. Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, Ahmed AI, Shaman M, Lannaman K, Yoon BH, Hassan SS, Kim CJ, Korzeniewski SJ, Yeo L, Kim YM: Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2015; 28:1394-1409.
89. Bredeson S, Papaconstantinou J, Deford JH, Kechichian T, Syed T, Saade G, Menon R: HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes. PLoS ONE 2014; 9:e113799.
90. Casey ML, MacDonald PC: The endocrinology of human parturition. Ann N Y Acad Sci 1997; 828:273-284.
91. Parizek A, Koucky M, Duskova M: Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol 2014; 139:159-165.
92. Smith R, Nicholson RC: Corticotrophin releasing hormone and the timing of birth. Front Biosci 2007; 12:912-918.
93. Menon R, Fortunato SJ, Yu J, Milne G, Sanchez S, Drobek C, Lappas M, Taylor R: Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta 2011; 32:317-322.
94. Menon R, Boldogh I, Hawkins HK, Woodson M, Polettini J, Syed TA, Fortunato SJ, Saade GR, Papaconstantinou J, Taylor RN: Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol 2014; 184:1740-1751.
95. Menon R: Oxidative stress damage as a detrimental factor in preterm birth pathology. Front Immunol 2014; 5:567.
96. Menon R, Polettini J, Syed TA, Saade GR, Boldogh I: Expression of 8-oxoguanine Glycosylase in Human Fetal Membranes. Am J Reprod Immunol 2014; 72:75-84.
97. Menon R, Boldogh I, Urrabaz-Garza R, Polettini J, Syed TA, Saade GR, Papaconstantinou J, Taylor RN: Senescence of primary amniotic cells via oxidative DNA damage. PLoS ONE 2013; 8:e83416.
98. Brancho D, Tanaka N, Jaeschke A, Ventura J, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell R, Davis R: Mechanism of p38 MAP kinase activation in vivo. Genes Dev 2003; 17:1969-1978.
99. Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007; 1773:1358-1375.
100. Natale DR, Paliga AJ, Beier F, D'Souza SJ, Watson AJ: p38 MAPK signaling during murine preimplantation development. Dev Biol 2004; 268:76-88.
101. Thornton TM, Rincon M: Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 2009; 5:44-51.
102. Torres M: Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 2003; 8:d369-d391.
103. Coppe JP, Desprez PY, Krtolica A, Campisi J: The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5:99-118.
104. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz D, Goldstein J, Nelson P, Desprez P, Campisi J: Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-2868.
105. Davalos AR, Coppe JP, Campisi J, Desprez PY: Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 2010; 29:273-283.
106. Behnia F, Peltier MR, Saade GR, Menon R: Environmental pollutant polybrominated diphenyl ether, a flame retardant, induces primary amnion cell senescence. Am J Reprod Immunol 2015; 74:398-406.
107. Ames BN: Endogenous DNA damage as related to cancer and aging. Mutat Res 1989; 214:41-46.
108. Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF: Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 2013; 13:746-758.
109. Chen HI, Liou SH, Ho SF, Wu KY, Sun CW, Chen MF, Cheng LC, Shih TS, Loh CH: Oxidative DNA damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4, 4'-methylenebis (2-chloroaniline) exposure and smoking. J Occup Health 2007; 49:389-398.
110. Chen L, Bowen PE, Berzy D, Aryee F, Stacewicz-Sapuntzakis M, Riley RE: Diet modification affects DNA oxidative damage in healthy humans. Free Radic Biol Med 1999; 26:695-703.
111. Daube H, Scherer G, Riedel K, Ruppert T, Tricker AR, Rosenbaum P, Adlkofer F: DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status. J Cancer Res Clin Oncol 1997; 123:141-151.
112. Kaneko T, Tahara S, Matsuo M: Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 1996; 316:277-285.
113. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pastermakc A, Alho H: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417:150-152.
114. Marczynski B, Kraus T, Rozynek P, Raithel HJ, Baur X: Association between 8-hydroxy-2'-deoxyguanosine levels in DNA of workers highly exposed to asbestos and their clinical data, occupational and non-occupational confounding factors, and cancer. Mutat Res 2000; 468:203-212.
115. Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, Endo F.: Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002; 36:189-193.
116. Peter ST, Scholl TO, Schluter MD, Leskiw MJ, Chen X, Spur BW, Rodriguez A: Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res 2008; 42:841-848.
117. Subash P, Gurumurthy P, Sarasabharathi A, Cherian KM: Urinary 8-OHdG: A marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem 2010; 25:127-132.
118. Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC: 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 2000; 36:934-944.
119. Tsukahara H, Haruta T, Ono N, Kobata R, Fukumoto Y, Hiraoka M, Mayumi M: Oxidative stress in childhood meningitis: measurement of 8-hydroxy-2'-deoxyguanosine concentration in cerebrospinal fluid. Redox Rep 2000; 5:295-298.
120. Wu LL, Chiou CC, Chang PY, Wu JT: Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339:1-9.
121. Milne GL, Yin H, Morrow JD: Human biochemistry of the isoprostane pathway. J Biol Chem 2008; 283:15533-15537.
122. Morrow JD, Roberts LJ: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36:1-21.
123. Morrow JD, Roberts LJ: Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress. Methods Mol Biol 2002; 186:57-66.
124. Menon R, Fortunato SJ, Yu J, Milne GL, Sanchez S, Drobek CO, Lappas M, Taylor RN: Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta 2011; 32:317-322.
125. Lappas M, Permezel M, Rice GE: Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissues. Placenta 2007; 28:936-945.
126. Jung HS, Yoon BH, Jun JK, Kim M, Kim YA, Kim CJ: Differential activation of mitogen activated protein kinases and nuclear factor-kappaB in lipopolysaccharide-treated term and preterm amnion cells. Virchows Arch 2005; 447:45-52.
127. Harbo M, Koelvraa S, Serakinci N, Bendix L: Telomere dynamics in human mesenchymal stem cells after exposure to acute oxidative stress. DNA Repair (Amst) 2012; 11:774-779.
128. Lindstrom TM, Bennett PR: The role of nuclear factor kappa B in human labour. Reproduction 2005; 130:569-581.
129. Lappas M: NOD1 and NOD2 regulate proinflammatory and prolabor mediators in human fetal membranes and myometrium via nuclear factor-kappa B. Biol Reprod 2013; 89:14.
130. Allport VC, Slater DM, Newton R, Bennett PR: NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000; 6:561-565.
131. Khanjani S, Kandola MK, Lindstrom TM, Sooranna SR, Melchionda M, Lee YS, Terzidou V, Johnson MR, Bennett PR: NF-kappaB regulates a cassette of immune/inflammatory genes in human pregnant myometrium at term. J Cell Mol Med 2011; 15:809-824.
132. Lei K, Chen L, Georgiou EX, Sooranna SR, Khanjani S, Brosens JJ, Bennett PR, Johnson MR: Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1beta-induced COX-2 expression in human term myometrial cells. PLoS ONE 2012; 7:e50167.
133. Macintyre DA, Sykes L, Teoh TG, Bennett PR: Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med 2012; 25(Suppl 1):17-20.
134. Olson DM, Ammann C: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007; 12:1329-1343.
135. Blaecke A, Delneste Y, Herbault N, Jeannin P, Bonnefoy JY, Beck A, Aubry JP: Measurement of nuclear factor-kappa B translocation on lipopolysaccharide-activated human dendritic cells by confocal microscopy and flow cytometry. Cytometry 2002; 48:71-79.
136. Korus M, Mahon GM, Cheng L, Whitehead IP: p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Oncogene 2002; 21:4601-4612.
137. Behnia F, Taylor BD, Woodson M, Kacerovsky M, Hawkins H, Fortunato SJ, Saade GR, Menon R: Chorioamniotic Membrane Senescence: a Signal for Parturition? Am J Obstet Gynecol 2015; 213:e1-e16.
138. Polettini J, Behnia F, Taylor BD, Saade GR, Taylor RN, Menon R: Telomere fragment induced amnion cell senescence: a contributor to parturition? PLoS ONE 2015; 10:e0137188.
139. Shen H, Kreisel D, Goldstein DR: Processes of sterile inflammation. J Immunol 2013; 191:2857-2863.
140. Rubartelli A, Lotze MT, Latz E, Manfredi A: Mechanisms of sterile inflammation. Front Immunol 2013; 4:398.